SCHEMBL303343

SCHEMBL303343

O=c1ccn[c][nH]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1854290 0.68
SCHEMBL6860487 0.58
SCHEMBL467461 0.54
SCHEMBL17137826 0.53
Water SCHEMBL21439849 0.53
Bromide SCHEMBL2338080 0.53
SCHEMBL4302333 0.53
Water SCHEMBL21439848 0.53 KDM4A (0.36)
SCHEMBL31118006 0.51
SCHEMBL818 0.49

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1031 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3160517-B1 WATER-SOLUBLE ACTIVATABLE MOLECULAR PROBES, INTERMEDIATES FOR THE SYNTHESIS THEREOF AND ASSOCIATED DETECTION METHODS ECOLE NORMALE SUPERIEURE LYON (FR) 2024-06-12 EP claimed
US-20240158414-A1 BI-ARYL DIHYDROOROTATE DEHYDROGENASE INHIBITORS JANSSEN BIOTECH, INC. 2024-05-16 US claimed
WO-2024035950-A1 INHIBITORS OF KIF18A AND USES THEREOF ACCENT THERAPEUTICS, INC. (US) 2024-02-15 WO claimed
WO-2024029877-A1 NOVEL PURINE DERIVATIVE COMPOUNDS AS A3 ADENOSINE RECEPTOR AGONISTS 주식회사 넥스트젠바이오사이언스 2024-02-08 WO claimed
EP-4041714-B1 BI-ARYL DIHYDROOROTATE DEHYDROGENASE INHIBITORS JANSSEN BIOTECH INC (US) 2023-12-13 EP claimed
EP-3555112-B1 FLUOROGENIC GLYCOSIDASE SUBSTRATE AND ASSOCIATED DETECTION METHOD ECOLE NORMALE SUPERIEURE LYON (FR) 2023-12-06 EP claimed
CN-109983012-B Ketone inhibitors of lysine gum protease 莱特豪斯制药公司 2023-12-01 CN claimed
CN-110088089-B Benzyl amino pyridyl cyclopropane carboxylic acid, pharmaceutical composition and application thereof 勃林格殷格翰国际有限公司 2023-08-29 CN claimed
CN-110177773-B Benzyl aminopyridine cyclopropanecarboxylic acid, pharmaceutical composition and application thereof 勃林格殷格翰国际有限公司 2023-08-25 CN claimed
CN-110248929-B Benzyl amino pyrazinyl cyclopropanecarboxylic acid, pharmaceutical composition and use thereof 勃林格殷格翰国际有限公司 2023-05-12 CN claimed
WO-1993014069-A1 HETEROCYCLIC SULFONAMIDE DERIVATIVES AS ANTAGONISTS OF PAF AND ANGIOTENSIN II BRITISH BIO-TECHNOLOGY LIMITED (GB) 1993-07-22 WO claimed
EP-0539421-A1 NOVEL OXAZOLYL DERIVATIVES JANSSEN PHARMACEUTICA N.V. (BE) 1993-05-05 EP claimed
EP-0234356-B1 PHOSPHORIC-ACID ESTERS BAYER AG (DE) 1989-07-26 EP claimed
EP-0234356-A1 Phosphoric-acid esters BAYER AG (DE) 1987-09-02 EP claimed
US-4689321-A CYTOLYSIS, ANTITUMOR, ANTICARCINOGENIC THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) 1987-08-25 US claimed
EP-0222598-A2 Dihydropyridine anti-ischaemic and antihypertensive agents Pfizer Limited (GB) 1987-05-20 EP claimed
US-4661485-A 2-pyrimidylaminoalkoxymethyl-6-methyl-3,5-bis (alkoxycarbony-1)-1,4-dihydropyridine antihypertensive agents PFIZER INC. (US) 1987-04-28 US claimed
EP-0139917-A1 Pharmaceutical preparations, acylated hydrazine derivatives, methods for their preparation CIBA-GEIGY AG (CH) 1985-05-08 EP claimed
US-4172197-A BACTERICIDES ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) 1979-10-23 US claimed
US-4091211-A ANTIBIOTICS HOFFMANN-LA ROCHE INC. (US) 1978-05-23 US claimed